BARCELONA, Spain, April 18, 2023 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF) (MCE:GRF.P) (NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years, today announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission ("SEC").
Read more at prnewswire.comGrifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/Image%20of%20server%20racks%20in%20modern%20server%20room%20data%20center%20by%20Sashkin%20via%20Shutterstock.jpg)
